DE69840752D1 - Verwendung von coumarine zur behandlung von lebererkrankungen und pankreaserkrankungen - Google Patents

Verwendung von coumarine zur behandlung von lebererkrankungen und pankreaserkrankungen

Info

Publication number
DE69840752D1
DE69840752D1 DE69840752T DE69840752T DE69840752D1 DE 69840752 D1 DE69840752 D1 DE 69840752D1 DE 69840752 T DE69840752 T DE 69840752T DE 69840752 T DE69840752 T DE 69840752T DE 69840752 D1 DE69840752 D1 DE 69840752D1
Authority
DE
Germany
Prior art keywords
diseases
coumarine
treatment
pancreas
liver
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69840752T
Other languages
English (en)
Inventor
Mladen Trkovnik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bio Monde Preparations Ltd
Original Assignee
Bio Monde Preparations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Monde Preparations Ltd filed Critical Bio Monde Preparations Ltd
Application granted granted Critical
Publication of DE69840752D1 publication Critical patent/DE69840752D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Saccharide Compounds (AREA)
DE69840752T 1997-10-24 1998-10-22 Verwendung von coumarine zur behandlung von lebererkrankungen und pankreaserkrankungen Expired - Fee Related DE69840752D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9722600.5A GB9722600D0 (en) 1997-10-24 1997-10-24 Pharmaceutical compositon
PCT/GB1998/003169 WO1999021550A1 (en) 1997-10-24 1998-10-22 Use of coumarin derivatives for the treatment of digestive tract disorders

Publications (1)

Publication Number Publication Date
DE69840752D1 true DE69840752D1 (de) 2009-05-28

Family

ID=10821112

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69840752T Expired - Fee Related DE69840752D1 (de) 1997-10-24 1998-10-22 Verwendung von coumarine zur behandlung von lebererkrankungen und pankreaserkrankungen

Country Status (9)

Country Link
US (1) US6407073B1 (de)
EP (1) EP1024805B1 (de)
JP (1) JP2001520994A (de)
KR (1) KR20010031407A (de)
AU (1) AU9551298A (de)
DE (1) DE69840752D1 (de)
GB (1) GB9722600D0 (de)
WO (1) WO1999021550A1 (de)
ZA (1) ZA989680B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001236982A1 (en) * 2000-02-11 2001-08-20 Musc Foundation For Research Development A method of treating colon cancer by administering apigenin, luteolin, diosmetinand crysin
AU2002222589A1 (en) * 2000-12-08 2002-06-18 Kyowa Hakko Kogyo Co. Ltd. Oral preprations having itching-relievign or antipruritic activity
KR100768024B1 (ko) * 2001-04-10 2007-10-18 다카라 바이오 가부시키가이샤 치료제
ES2249391T3 (es) * 2001-12-04 2006-04-01 MAC PHARMA S.A.S. DI PAOLA MICHIELETTO & C. Uso de cumarina o su derivado hidroxilado para el tratamniento del edema vascular y/o linfatico medio o grave.
CN1506359A (zh) 2002-12-05 2004-06-23 �й�ҽѧ��ѧԺҩ���о��� 新的香豆素酰胺衍生物及其制法和其药物组合物与用途
US7538233B2 (en) 2003-09-05 2009-05-26 Aventis Pharmaceuticals Inc. Coumarins as iNOS inhibitors
KR100651278B1 (ko) * 2004-12-29 2006-11-29 엘지전자 주식회사 냉장고의 서랍 장착구조
AR059339A1 (es) 2006-02-09 2008-03-26 Chugai Pharmaceutical Co Ltd Derivados de la cumarina para trastornos proliferativos de celulas, composicion farmaceutica y agente terapeutico que los contiene
US20100168225A1 (en) * 2007-04-18 2010-07-01 Francois Jean Small-Molecule Hepatitis C Virus (HCV) NS3/4A Serine Protease Inhibitors
EP2172198B1 (de) 2007-07-20 2014-04-16 Chugai Seiyaku Kabushiki Kaisha P27-protein-induktor
KR101133246B1 (ko) * 2010-02-24 2012-04-05 원광대학교산학협력단 신규한 코마린 유도체, 이의 제조방법 및 상기 코마린 유도체를 포함하는 형광 면역측정용 키트
FR2968552B1 (fr) * 2010-12-14 2012-12-28 Rocher Yves Biolog Vegetale Utilisation cosmetique d'un extrait de manne de frene
CN105579578A (zh) * 2013-08-12 2016-05-11 贝纳罗亚研究院·弗吉尼亚梅森 用于免疫调节的4-甲基伞形酮治疗
US11278518B2 (en) 2017-01-13 2022-03-22 The Board Of Trustees Of The Leland Stanford Junior University Methods of treatment using 4-methylumbelliferone and derivatives thereof
CN110354119A (zh) * 2018-03-26 2019-10-22 中国农业大学 甘草香豆素在制备预防和/或治疗药物性肝损伤的药物中的应用
RU2733719C1 (ru) * 2019-04-23 2020-10-06 Общество С Ограниченной Ответственностью "Валента - Интеллект" Комбинация для лечения функциональных заболеваний органов желудочно-кишечного тракта
RU2752086C1 (ru) * 2020-04-27 2021-07-22 Общество С Ограниченной Ответственностью "Валента-Интеллект" Новое соединение [2-(диметиламино)-2-фенилбутил]-3,4,5-триметоксибензоата 4-метил-2н-хромен-2-он-7-илсульфат и его применение
KR20240055228A (ko) 2022-10-19 2024-04-29 서울대학교산학협력단 췌장 라이페이스 저해 기능을 가지는 스키민

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1430M (fr) 1961-07-13 1962-08-06 Lipha Nouveau médicament cholérétique de la série de la coumarine.
US4241047A (en) 1979-07-18 1980-12-23 Lipha, Lyonnaise Industrielle Pharmaceutique Novel medicinal composition for the treatment of biliary lithiasis
US5281721A (en) 1984-08-20 1994-01-25 Georgia Tech Research Corporation Heterocyclic inhibitors of serine proteases
DE3611467A1 (de) 1986-04-05 1987-10-08 Dolorgiet Gmbh & Co Kg Hochresorbierbare zubereitungsform des hymecromons und verfahren zur herstellung derselben
FR2726435B1 (fr) 1994-11-07 1997-01-24 Dukan Pierre Substitut sensoriel de l'envie de fumer facilitant la desaccoutumance au tabac

Also Published As

Publication number Publication date
KR20010031407A (ko) 2001-04-16
JP2001520994A (ja) 2001-11-06
WO1999021550A1 (en) 1999-05-06
EP1024805B1 (de) 2009-04-15
US6407073B1 (en) 2002-06-18
ZA989680B (en) 1999-07-23
GB9722600D0 (en) 1997-12-24
AU9551298A (en) 1999-05-17
EP1024805A1 (de) 2000-08-09

Similar Documents

Publication Publication Date Title
DE69836752D1 (de) Prostaglandinagoniste und deren verwendung zur behandlung von knochenerkrankungen
DE69724016D1 (de) Verwendung von anti-mikrotubuli mitteln zur behandlung von entzündlichen erkrankungen der atemwege
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
DE69927971D1 (de) Verwendung von peg-ifn-alpha und ribavirin zur behandlung chronischer hepatitis c
DE69840752D1 (de) Verwendung von coumarine zur behandlung von lebererkrankungen und pankreaserkrankungen
DE69836915D1 (de) Mundpflegemittel zur behandlung von übelriechendem atem
ATE308997T1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
ATE527022T1 (de) Verwendung von cyclooxygenase-2-inhibitoren zur behandlung und vorbeugung von tumoren, von tumor- abhängigen erkrankungen und kachexie
ATE271038T1 (de) 4-phenylpiperidine zur behandlung von prutitischen hauterkrankungen
DE69812784D1 (de) Zusammensetzung zur Vorbeugung und Beseitigung von Pflanzenkrankheiten
DE69841984D1 (de) Zusammensetzung aus nanokapseln zur behandlung von intraarticulaeren erkrankungen
DE69734296D1 (de) Neue dikaffeoylchinasäurederivate und deren verwendung zur behandlung von hepatitis b
DE69807466T2 (de) Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten
DE69841550D1 (de) Behandlung von fibromyalgie und verwandten erkrankungen
DE69912670D1 (de) Substituierte tricyclische Verbindungen und deren Verwendung zur Behandlung von sPLA2-bedingten Erkrankungen
DE60027429D1 (de) Dihydrobenzodiazepinen und deren verwendung zur behandlung von dyslipidämien
DE69825319D1 (de) Präparat zur vorbeugung und behandlung von entzündungen
DE69931487D1 (de) Verwendung von apomorphin zur behandlung der vorzeitigen ejakulation
DE69729735D1 (de) Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen
DE69822297D1 (de) Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten
DE59704933D1 (de) Verwendung von PHMB zur Behandlung von Tumorerkrankungen
DE69837148D1 (de) Chimäre proteine zur behandlung von diabetes
DE69913380D1 (de) Zusammensetzung zur behandlung von periodontalen erkrankungen
DE69834937D1 (de) Antibiotika zur behandlung von magengeschwuren
ATE346840T1 (de) Aminoalkylphenol-derivate zur behandlung von depression und gedächtnis-funktionsstörung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee